Asia Pacific Apac Bioinformatics Market
Taille du marché en milliards USD
TCAC : %
Période de prévision |
2023 –2029 |
Taille du marché (année de référence) |
|
Taille du marché (année de prévision) |
USD 11.30 Billion |
TCAC |
|
Principaux acteurs du marché |
|
>Marché de la bioinformatique en Asie-Pacifique, par type (outils de gestion des connaissances, logiciels et services de bioinformatique), secteur (biotechnologie médicale, universitaires, biotechnologie animale, biotechnologie agricole, biotechnologie environnementale, biotechnologie médico-légale et autres), application (génomique et développement de médicaments, protéomique, études évolutives, études agricoles, sciences vétérinaires, métabolomique , transcriptomique et autres), mode d'achat (achat groupé et achat individuel), méthode (génomique et protéomique), utilisateur final (instituts de recherche et universitaires, organisation de recherche clinique, sociétés de biotechnologie et pharmaceutiques, laboratoires de recherche, hôpitaux et autres) - Tendances et prévisions de l'industrie jusqu'en 2029.
Analyse et perspectives du marché de la bioinformatique en Asie-Pacifique
L'augmentation de la demande d'outils avancés de bioinformatique computationnelle, de transcriptomique et de protémie dans la recherche en biologie moléculaire, suivie d'une augmentation des exigences en matière de bioinformatique intégrée dans les diagnostics protéomiques, génomiques et cliniques, et de nombreuses organisations de bioinformatique fournissant des ressources d'externalisation devraient stimuler la croissance du marché.
Cependant, le manque d’expertise qualifiée et formée pour utiliser les outils informatiques devrait freiner la croissance du segment.
Le partenariat accru avec les acteurs du marché pour l'utilisation de logiciels de bioinformatique devrait stimuler la croissance du marché. Data Bridge Market Research analyse que le marché de la bioinformatique en Asie-Pacifique connaîtra un TCAC de 17,8 % au cours de la période de prévision de 2022 à 2029.
Rapport métrique |
Détails |
Période de prévision |
2022 à 2029 |
Année de base |
2021 |
Années historiques |
2020 (personnalisable de 2019 à 2014) |
Unités quantitatives |
Chiffre d'affaires en millions USD, prix en USD |
Segments couverts |
Par type (outils de gestion des connaissances, logiciels et services de bioinformatique), secteur (biotechnologie médicale, universitaires, biotechnologie animale, biotechnologie agricole, biotechnologie environnementale, biotechnologie médico-légale et autres), application (génomique et développement de médicaments, protéomique, études évolutives, études agricoles, sciences vétérinaires, métabolomique, transcriptomique et autres), mode d'achat (achat groupé et achat individuel), méthode (génomique et protéomique), utilisateur final (instituts de recherche et universitaires, organismes de recherche clinique, sociétés biotechnologiques et pharmaceutiques, laboratoires de recherche, hôpitaux et autres) |
Pays couverts |
Chine, Japon, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, Reste de l'Asie-Pacifique |
Acteurs du marché couverts |
Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Waters Corporation, Partek Incorporated, Dassault Système, Bayer AG, PerkinElmer Inc., Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, Strand Life Science, GenoFAB, Inc. |
Définition du marché
Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, Bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, etc.
In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify quality targets
Asia-Pacific Bioinformatics Market Dynamics
Drivers
- Increasing Public-Private Sector Funding For Bioinformatics
In order to improve the workflow for bioinformatics, the federal agencies and the public and private agencies are providing funds to carry out bioinformatics projects and to scientists for research. It is important to approach possible funders with a clear proposal and strategy of what is to be achieved in terms of bioinformatics capacity building in the institution as well as the intended outputs and outcomes.
For instance;
- In April 2022, Illumina, Inc. initiated the six-month cyclic funding in the San Francisco Bay Area or Cambridge, the U.K., for bioinformatics start-up
- In October 2020, SOPHiA GENETICS raised USD 110 million for financing for the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for Data-Driven Medicine worldwide
The funding by the public and private sectors would result in the rise of bioinformatics startups and projects. The funding would expedite and expand the institute's technical infrastructure. This includes setting up new data storage solutions and scaling existing data resources. The funding will also be used to provide secure, shared analysis platforms for major research collaborations. Hence the public-private sector funding for bioinformatics is expected to drive market growth.
- Use of Bioinformatics in Personalized Medicine
The growth curve for bioinformatics market clinical applications is following an upward trend as established applications are gaining momentum and new ones are finding a foothold. Product development in the past years has helped the market size to grow. This also shows the support of the regulatory agency for allowing these products in the market.
For instance-
- In June 2021, Agilent Technologies, Inc. released a new exome design called Sure Select Human All Exon V8 that offers specific content and coverage of protein-coding areas from Refuses, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which are neglected by competing exomes
The product development in recent years has shown the potential of these technologies, and the companies working in this market are trying to get the more advanced product in the market, which is expected to create a lucrative opportunity for market growth in the forecast period.
Opportunities
- Strategic Initiatives by Market Players
Bioinformatics delivers purposeful biological information, as it is a part of life science dealing with the comprehension and planning of genomes. A genome is the complex arrangement of genetic sets present in a cell or a whole living being. Personalized medicine is a combinatorial way to deal with individual-specific health care. The patient-specific medication development advanced through bioinformatics tools.
For instance-
- In December 2020, Quest Diagnostics Incorporated invested in Structural Bioinformatics, A Leader in Computational Proteomics and Structural Pharmacogenomics. The investment resulted in the joint development of a series of database modules of the novel, structurally variant proteins and market these products directly to the pharmaceutical and biotechnology industry for use in the development of personalized medicine
- In 2019, BGI announced that Flow Pharma had selected BGI (A subsidiary of BGI Group) for developing the use of NSG in Drug Development
Hence the growing prevalence of chronic disease and increased drug-resistance issues in traditional medication have generated the demand for increasing bioinformatics in drug development. This is expected to be one of the major factors expected to drive the market growth in the forecast period.
- Advancement in bioinformatics technology
The dimensions and cost of bioinformatics platforms and instruments are decreasing, allowing easier uptake by public health laboratories. Although currently, bioinformatics requires highly specialized equipment and substantially skilled staff to analyze the data, it is unlikely that the bioinformatics revolution has finished. With rising technology, up-gradation of instruments and techniques is also needed. Moreover, the bioinformatics market has a vast potential to upgrade various applications, and there are high chances of advancing bioinformatics techniques in the forecast period.
- E-Health.
E-health equipment and technologies. Processing of information in e-health. Services and applications for telemedicine and e-health. Image processing in medicine. Medical imaging approaches using video. Combining traditional treatment with electronic health
With time, technological advancements put pressure on manufacturers and researchers to change instruments and techniques to cope with modern problems. Thus bioinformatics has the potential to get updated with time and is expected to create opportunities for the new player and existing players to bring a new product to the market.
Restraints/Challenges
- Challenges to Implementing Bioinformatics Technology in The Clinical Labs
Bioinformatics technologies can perform massively complicated biological data analysis. This capacity simultaneously facilitates the computational tools for the organization and analysis of biological data, which helps improve diagnostic screening. The application of these powerful technologies in a clinical laboratory poses a challenge because of the data's scope, quantity, and medico-technical consequences.
Various challenges of implementing next-generation sequencing in the clinical laboratory are as follows-
- One of the first areas where problems can creep in is often the most overlooked: "sample quality". Although platforms are often tested and compared using highly curated samples (such as the reference material from the Genome in a Bottle Consortium), real-world samples often present much more of a challenge and hence act as a challenge for the rise in demand.
- High turn-around time is also a major challenge for the instruments working in this market.
- Library Preparation
The above challenge poses complications for adopting bioinformatics in the clinical laboratory, due to which fewer clinical laboratories are adopting this technology. Thus, the challenges of implementing bioinformatics technology in the clinical lab are expected to hamper the market growth.
- Cyber Security Concerns in Bioinformatics
Era software is known to contain vulnerabilities caused by imperfect code and misconfiguration. NGS-related software used to operate sequencing and laboratory equipment or carry out bioinformatics analyzes is no exception. Software vulnerabilities are exploited to gain unauthorized access to computer systems or networks, leak data, crash or otherwise disrupt various services.
However, the increasing computerization of DNA technology and biotechnology raises new bio-cyber security concerns. Vulnerabilities typically associated with traditional computer systems -- like the processing of untrusted input, side-channel leaks, poor authentication, falsified data, and vulnerabilities in cyber-physical systems -- now exist in biotechnology. The emerging bio-cyber security threats have threatened the DNA-Information Systems in bioinformatics.
For instance;
- In 2020, The REvil or Sodinokibi ransomware group will take the credit for hacking and stealing 1 Terabyte (TB) of data from 10x Genomics which is for COVID-19 research
- En 2018, Genomics England a transféré les données de son projet 100 000 génomes après avoir été la cible de cyberattaques de la part de parties étrangères. Cela permet la violation des données et peut conduire à une utilisation abusive du génome individuel
Impact du COVID-19 sur le marché de la bioinformatique en Asie-Pacifique
Pendant la pandémie, le secteur de la bioinformatique de la région Asie-Pacifique s'est concentré sur l'utilisation d'une combinaison de biologie et de technologies de l'information. Les données biologiques sont analysées et transformées au cœur de l'industrie à l'aide de techniques informatiques. La bioinformatique a toujours eu un énorme potentiel pour fournir un soutien essentiel à de nombreux domaines de la recherche scientifique. L'industrie de la bioinformatique en Asie-Pacifique a connu des opportunités de croissance rapide avant la pandémie grâce à des outils bioinformatiques efficaces, capables de gérer de grands volumes de données biologiques.
Les outils que la bioinformatique peut fournir permettent aux scientifiques de se familiariser avec des ensembles de données plus volumineux et de les exploiter et de les analyser pour découvrir des informations cruciales qui pourraient conduire à des découvertes clés. Ces dernières années, la génétique et les génomes ont été au cœur des préoccupations de la bioinformatique, notamment la génomique comparative, les puces à ADN et la génomique fonctionnelle. La pandémie de COVID-19 a vu une application généralisée des approches génomiques pour comprendre l'épidémiologie et l'évolution du virus SARS-CoV-2. Les efforts accélérés pour séquencer les génomes du SARS-CoV-2 se sont accélérés après le séquençage initial du génome du virus d'un patient de Wuhan, l'épicentre de la pandémie avec une augmentation substantielle lors de l'émergence de variants du virus SARS-CoV-2.
Développement récent
- En mars 2022, Thermo Fisher Scientific Inc a lancé l'instrument de séquençage de nouvelle génération (NGS) marqué CE-IVD destiné à être utilisé dans les laboratoires cliniques. L'instrument de séquençage de nouvelle génération marqué CE-IVD est utilisé pour effectuer des tests de diagnostic et des recherches cliniques sur un seul instrument. Le lancement de l'instrument a donné lieu à l'ajout d'un nouveau produit dans la gamme de produits et à la distribution de l'instrument NGS, ce qui devrait augmenter les revenus du produit.
Portée du marché de la bioinformatique en Asie-Pacifique
Le marché de la bioinformatique en Asie-Pacifique est segmenté sur la base de six segments : type, secteur, application, mode d’achat, génomique et utilisateur final. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.
Taper
- Outils de gestion des connaissances
- Logiciel de bioinformatique
- Services
Sur la base du type, le marché de la bioinformatique en Asie-Pacifique est segmenté en outils de gestion des connaissances, logiciels de bioinformatique et services.
Secteur
- Biotechnologie médicale
- Universitaires
- Biotechnologie animale
- Biotechnologie agricole
- Biotechnologie environnementale
- Biotechnologie médico-légale
- Autres
Sur la base du secteur, le marché de la bioinformatique Asie-Pacifique est segmenté en biotechnologie médicale, universitaire, biotechnologie animale, biotechnologie agricole, biotechnologie environnementale, biotechnologie médico-légale et autres.
Application
- Génomique et développement de médicaments
- Protéomique
- Études évolutives
- Études agricoles
- Sciences vétérinaires
- Métabolomique
- Transcriptomique
- Autres
Sur la base des applications, le marché de la bioinformatique de la région Asie-Pacifique est segmenté en génomique et développement de médicaments, protéomique, études évolutives, études agricoles, sciences vétérinaires, métabolomique, transcriptomique et autres.
Mode d'achat
- Achat groupé
- Achat individuel
Sur la base du mode d’achat, le marché de la bioinformatique Asie-Pacifique est segmenté en achats groupés et achats individuels.
Méthode
- Génomique
- Protéomique
Sur la base de la méthode, le marché de la bioinformatique de la région Asie-Pacifique est segmenté en génomique et protéomique.
Utilisateur final
- Instituts de recherche et d'enseignement
- Organisation de recherche clinique
- Sociétés de biotechnologie et pharmaceutiques
- Laboratoires de recherche
- Hôpital
- Autres
Sur la base de l'utilisateur final, le marché de la bioinformatique Asie-Pacifique est segmenté en instituts de recherche et universitaires, organisations de recherche clinique, sociétés biotechnologiques et pharmaceutiques, laboratoires de recherche, hôpitaux et autres.
Analyse/perspectives régionales du marché de la bioinformatique en Asie-Pacifique
Le marché de la bioinformatique en Asie-Pacifique est analysé et les régions fournissent des informations sur la taille et les tendances du marché, le type, le secteur, l’application, le mode d’achat, la génomique et l’utilisateur final, comme référencé ci-dessus.
Les pays couverts dans le rapport sur le marché de la bioinformatique en Asie-Pacifique sont la Chine, le Japon, l’Inde, la Corée du Sud, l’Australie, Singapour, la Thaïlande, la Malaisie, l’Indonésie, les Philippines et le reste de l’Asie-Pacifique.
La Chine devrait dominer le marché en raison de l'augmentation de l'incidence de l'augmentation des activités de recherche et développement et en raison des exigences bioinformatiques intégrées dans les diagnostics protéomiques, génomiques et cliniques, combinées à la demande croissante d'outils informatiques avancés dans la recherche biologique.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie des pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales ont un impact sur les canaux de vente et sont prises en compte lors de l'analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché de la bioinformatique en Asie-Pacifique
Le paysage concurrentiel du marché de la bioinformatique en Asie-Pacifique fournit des détails sur le concurrent. Les détails comprennent un aperçu de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Asie-Pacifique, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché de la bioinformatique en Asie-Pacifique.
Certains des principaux acteurs opérant sur le marché de la bioinformatique en Asie-Pacifique sont Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Waters Corporation, Partek Incorporated, Dassault Système, Bayer AG, PerkinElmer Inc., Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, Strand Life Science, GenoFAB, Inc.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC BIOINFORMATICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 TYPE SEGMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 THE CATEGORY VS TIME GRID
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 REGULATIONS OF THE ASIA PACIFIC BIOINFORMATICS MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE
6.1.2 GROWING NEED FOR BIOINFORMATICS
6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS
6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE
6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS
6.2 RESTRAINTS
6.2.1 HIGH COST OF INSTRUMENTATION
6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS
6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER
6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS
6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY
6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS
7 ASIA PACIFIC BIOINFORMATICS MARKET, BY TYPE
7.1 OVERVIEW
7.2 SERVICES
7.2.1 DIAGNOSTICS CONSULTATION
7.2.2 DATA ANALYSIS
7.2.2.1 STRUCTURAL
7.2.2.2 FUNCTIONAL
7.3 BIOINFORMATICS SOFTWARE
7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP
7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT
7.3.3 SEQUENCING DATA ANALYSIS
7.3.3.1 SEQUENCE ANALYSIS PLATFORM
7.3.3.2 SEQUENCE ALIGNMENT PLATFORM
7.3.3.3 SEQUENCE MANIPULATION PLATFORM
7.3.3.4 STRUCTURAL ANALYSIS PLATFORM
7.3.3.5 OTHERS
7.3.4 BIOLOGICAL DATA INTERPRETATION
7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS
7.3.5.1 SINGLE CELL GENE EXPRESSION
7.3.5.2 GENE EXPRESSION
7.3.5.3 VARIANT DETECTION
7.3.5.4 CNV ANALYSIS
7.3.5.5 METAGENOMICS
7.3.5.6 METHYLATION
7.3.5.7 CHIP-SEQ
7.3.5.8 NON-CODING RNA EXPRESSION
7.3.5.9 OTHERS
7.3.6 OTHERS
7.4 KNOWLEDGE MANAGEMENT TOOLS
7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
8 ASIA PACIFIC BIOINFORMATICS MARKET, BY SECTOR
8.1 OVERVIEW
8.2 MEDICAL BIOTECHNOLOGY
8.3 ACADEMICS
8.4 ANIMAL BIOTECHNOLOGY
8.5 AGRICULTURAL BIOTECHNOLOGY
8.6 ENVIRONMENTAL BIOTECHNOLOGY
8.7 FORENSIC BIOTECHNOLOGY
8.8 OTHERS
9 ASIA PACIFIC BIOINFORMATICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 GENOMICS & DRUG DEVELOPMENT
9.2.1 SERVICES
9.2.2 SEQUENCING PLATFORMS
9.2.3 KNOWLEDGE MANAGEMENT TOOLS
9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE
9.2.4.1 PREVENTIVE MEDICINE
9.2.4.2 MOLECULAR MEDICINE
9.2.4.3 PERSONALIZED MEDICINE
9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN
9.2.4.5 ANTIBIOTIC RESISTANCE
9.3 PROTEOMICS
9.3.1 SERVICES
9.3.2 SERVICES SEQUENCING PLATFORMS
9.3.3 KNOWLEDGE MANAGEMENT TOOLS
9.4 AGRICULTURAL STUDIES
9.4.1 SERVICES
9.4.2 SERVICES SEQUENCING PLATFORMS
9.4.3 KNOWLEDGE MANAGEMENT TOOLS
9.5 TRANSCRIPTOMICS
9.5.1 SERVICES
9.5.2 SERVICES SEQUENCING PLATFORMS
9.5.3 KNOWLEDGE MANAGEMENT TOOLS
9.6 METABOLOMICS
9.6.1 SERVICES
9.6.2 SERVICES SEQUENCING PLATFORMS
9.6.3 KNOWLEDGE MANAGEMENT TOOLS
9.7 EVOLUTIONARY STUDIES
9.7.1 SERVICES
9.7.2 SERVICES SEQUENCING PLATFORMS
9.7.3 KNOWLEDGE MANAGEMENT TOOLS
9.8 VETERINARY SCIENCE
9.8.1 SERVICES
9.8.2 SERVICES SEQUENCING PLATFORMS
9.8.3 KNOWLEDGE MANAGEMENT TOOLS
9.9 OTHERS
9.9.1 SERVICES
9.9.2 SERVICES SEQUENCING PLATFORMS
9.9.3 KNOWLEDGE MANAGEMENT TOOLS
10 ASIA PACIFIC BIOINFORMATICS MARKET, BY PURCHASE MODE
10.1 OVERVIEW
10.2 GROUP PURCHASE
10.3 INDIVIDUAL PURCHASE
11 ASIA PACIFIC BIOINFORMATICS MARKET, BY METHOD
11.1 OVERVIEW
11.2 GENOMICS
11.2.1 DNA
11.2.2 RNA
11.3 PROTEOMICS
12 ASIA PACIFIC BIOINFORMATICS MARKET, BY END USER
12.1 OVERVIEW
12.2 RESEARCH AND ACADEMIC INSTITUTES
12.3 CLINICAL RESEARCH ORGANIZATION
12.4 BIOTECH AND PHARMACEUTICAL COMPANIES
12.5 RESEARCH LABORATORIES
12.6 HOSPITALS
12.7 OTHERS
13 ASIA PACIFIC BIOINFORMATICS MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 SINGAPORE
13.1.7 THAILAND
13.1.8 MALAYSIA
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 REST OF ASIA-PACIFIC
14 ASIA PACIFIC BIOINFORMATICS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 BAYER AG
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 THERMO FISHER SCIENTIFIC INC
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 EUROFINS SCIENTIFIC
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 DASSAULT SYSTÈMES
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 AGILENT TECHNOLOGIES, INC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ASTRIDBIO TECHNOLOGIES INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 BGI (A SUBSIDIARY OF BGI GROUP)
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 BIOBAM
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 DNANEXUS INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 DNASTAR
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 GENOFAB, INC
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 ILLUMINA, INC
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 PARTEK INCORPORATED
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 PERKINELMER INC.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 QIAGEN
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 QUEST DIAGNOSTICS INCORPORATED (2021)
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 SEVEN BRIDGES GENOMICS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SOPHIA GENETICS
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 STRAND LIFE SCIENCES
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 WATERS CORPORATION
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 BIOINFORMATICSCOST PER SAMPLE
TABLE 2 ASIA PACIFIC BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC SERVICES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC MEDICAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC ACADEMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC ANIMAL TECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC AGRICULTURAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC ENVIRONMENTAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC FORENSIC BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC METABOLOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 38 ASIA PACIFIC BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC GROUP PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 ASIA PACIFIC INDIVIDUAL PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 ASIA PACIFIC BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 42 ASIA PACIFIC GENOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 ASIA PACIFIC GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 44 ASIA PACIFIC PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 ASIA PACIFIC BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC RESEARCH AND ACADEMIC INSTITUTES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 ASIA PACIFIC CLINICAL RESEARCH ORGANIZATION IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 ASIA PACIFIC BIOTECH AND PHARMACEUTICAL COMPANIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 ASIA PACIFIC RESEARCH LABORATORIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 ASIA PACIFIC HOSPITALS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 ASIA PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 ASIA-PACIFIC BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 53 ASIA-PACIFIC BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 ASIA-PACIFIC SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 55 ASIA-PACIFIC DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 56 ASIA-PACIFIC BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 57 ASIA-PACIFIC SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 ASIA-PACIFIC SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 59 ASIA-PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 60 ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 61 ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 62 ASIA-PACIFIC GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 63 ASIA-PACIFIC GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 ASIA-PACIFIC PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 65 ASIA-PACIFIC AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 66 ASIA-PACIFIC TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 67 ASIA-PACIFIC METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 68 ASIA-PACIFIC EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 69 ASIA-PACIFIC VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 70 ASIA-PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 71 ASIA-PACIFIC BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 72 ASIA-PACIFIC BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 73 ASIA-PACIFIC GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 74 ASIA-PACIFIC BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 75 CHINA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 76 CHINA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 77 CHINA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 78 CHINA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 79 CHINA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 80 CHINA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 81 CHINA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 82 CHINA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 83 CHINA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 84 CHINA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 85 CHINA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 86 CHINA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 87 CHINA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 88 CHINA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 89 CHINA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 90 CHINA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 91 CHINA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 92 CHINA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 93 CHINA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 94 CHINA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 95 CHINA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 96 CHINA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 97 JAPAN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 98 JAPAN SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 99 JAPAN DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 100 JAPAN BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 101 JAPAN SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 102 JAPAN SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 JAPAN KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 JAPAN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 105 JAPAN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 106 JAPAN GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 107 JAPAN GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 108 JAPAN PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 JAPAN AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 110 JAPAN TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 111 JAPAN METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 112 JAPAN EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 113 JAPAN VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 114 JAPAN OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 115 JAPAN BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 116 JAPAN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 117 JAPAN GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 118 JAPAN BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 119 INDIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 120 INDIA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 121 INDIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 122 INDIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 INDIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 124 INDIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 125 INDIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 126 INDIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 127 INDIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 128 INDIA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 129 INDIA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 130 INDIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 131 INDIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 132 INDIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 133 INDIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 134 INDIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 135 INDIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 136 INDIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 137 INDIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 138 INDIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 139 INDIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 140 INDIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 141 SOUTH KOREA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 142 SOUTH KOREA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 143 SOUTH KOREA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 144 SOUTH KOREA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 145 SOUTH KOREA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 146 SOUTH KOREA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 147 SOUTH KOREA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 148 SOUTH KOREA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 149 SOUTH KOREA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 150 SOUTH KOREA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 151 SOUTH KOREA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 152 SOUTH KOREA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 153 SOUTH KOREA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 154 SOUTH KOREA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 155 SOUTH KOREA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 156 SOUTH KOREA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 157 SOUTH KOREA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 158 SOUTH KOREA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 159 SOUTH KOREA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 160 SOUTH KOREA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 161 SOUTH KOREA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 162 SOUTH KOREA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 163 AUSTRALIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 164 AUSTRALIA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 165 AUSTRALIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 166 AUSTRALIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 167 AUSTRALIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 168 AUSTRALIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 169 AUSTRALIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 170 AUSTRALIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 171 AUSTRALIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 172 AUSTRALIA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 173 AUSTRALIA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 174 AUSTRALIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 175 AUSTRALIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 176 AUSTRALIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 177 AUSTRALIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 178 AUSTRALIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 179 AUSTRALIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 180 AUSTRALIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 181 AUSTRALIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 182 AUSTRALIABIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 183 AUSTRALIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 184 AUSTRALIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 185 SINGAPORE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 186 SINGAPORE SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 187 SINGAPORE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 188 SINGAPORE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 189 SINGAPORE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 190 SINGAPORE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 191 SINGAPORE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 192 SINGAPORE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 193 SINGAPORE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 194 SINGAPORE GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 195 SINGAPORE GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 196 SINGAPORE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 197 SINGAPORE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 198 SINGAPORE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 199 SINGAPORE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 200 SINGAPORE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 201 SINGAPORE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 202 SINGAPORE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 203 SINGAPORE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 204 SINGAPORE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 205 SINGAPORE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 206 SINGAPORE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 207 THAILAND BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 208 THAILAND SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 209 THAILAND DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 210 THAILAND BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 211 THAILAND SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 212 THAILAND SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 213 THAILAND KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 214 THAILAND BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 215 THAILAND BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 216 THAILAND GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 217 THAILAND GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 218 THAILAND PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 219 THAILAND AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 220 THAILAND TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 221 THAILAND METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 222 THAILAND EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 223 THAILAND VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 224 THAILAND OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 225 THAILAND BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 226 THAILAND BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 227 THAILAND GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 228 THAILANDBIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 229 MALAYSIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 230 MALAYSIA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 231 MALAYSIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 232 MALAYSIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 233 MALAYSIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 234 MALAYSIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 235 MALAYSIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 236 MALAYSIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 237 MALAYSIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 238 MALAYSIA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 239 MALAYSIA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 240 MALAYSIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 241 MALAYSIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 242 MALAYSIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 243 MALAYSIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 244 MALAYSIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 245 MALAYSIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 246 MALAYSIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 247 MALAYSIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 248 MALAYSIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 249 MALAYSIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 250 MALAYSIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 251 INDONESIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 252 INDONESIA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 253 INDONESIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 254 INDONESIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 255 INDONESIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 256 INDONESIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 257 INDONESIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 258 INDONESIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 259 INDONESIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 260 INDONESIA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 261 INDONESIA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 262 INDONESIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 263 INDONESIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 264 INDONESIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 265 INDONESIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 266 INDONESIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 267 INDONESIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 268 INDONESIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 269 INDONESIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 270 INDONESIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 271 INDONESIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 272 INDONESIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 273 PHILIPPINES BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 274 PHILIPPINES SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 275 PHILIPPINES DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 276 PHILIPPINES BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 277 PHILIPPINES SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 278 PHILIPPINES SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 279 PHILIPPINES KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 280 PHILIPPINES BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 281 PHILIPPINES BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 282 PHILIPPINES GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 283 PHILIPPINES GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 284 PHILIPPINES PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 285 PHILIPPINES AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 286 PHILIPPINES TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 287 PHILIPPINES METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 288 PHILIPPINES EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 289 PHILIPPINES VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 290 PHILIPPINES OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 291 PHILIPPINES BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 292 PHILIPPINES BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 293 PHILIPPINES GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 294 PHILIPPINESBIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 295 REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
Liste des figures
FIGURE 1 ASIA PACIFIC BIOINFORMATICS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC BIOINFORMATICS MARKET: GEOGRAPHIC SCOPE
FIGURE 3 ASIA PACIFIC BIOINFORMATICS MARKET: DATA TRIANGULATION
FIGURE 4 ASIA PACIFIC BIOINFORMATICS MARKET: SNAPSHOT
FIGURE 5 ASIA PACIFIC BIOINFORMATICS MARKET: BOTTOM-UP APPROACH
FIGURE 6 ASIA PACIFIC BIOINFORMATICS MARKET: TOP-DOWN APPROACH
FIGURE 7 ASIA PACIFIC BIOINFORMATICS MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 ASIA PACIFIC BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC BIOINFORMATICS MARKET: APPLICATION COVERAGE GRID
FIGURE 11 ASIA PACIFIC BIOINFORMATICS MARKET: THE CATEGORY VS TIME GRID
FIGURE 12 ASIA PACIFIC BIOINFORMATICS MARKET SEGMENTATION
FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ASIA PACIFIC DENTAL LABMARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 GROWING APPLICATIONS OF BIOINFORMATICS AND LOW COST OF BIOINFORMATICS SEQUENCING ARE EXPECTED TO DRIVE THE MARKET FOR ASIA PACIFIC BIOINFORMATICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 15 SERVICES SEGMENT ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC BIOINFORMATICS MARKET IN 2019 & 2026
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC BIOINFORMATICS MARKET
FIGURE 17 DECREASE IN COST OF PER BASE SEQUENCING
FIGURE 18 GROWING NEED FOR BIOINFORMATICS IN VITAL APPLICATIONS
FIGURE 19 ASIA PACIFIC BIOINFORMATICS MARKET: BY TYPE, 2021
FIGURE 20 ASIA PACIFIC BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 21 ASIA PACIFIC BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 22 ASIA PACIFIC BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC BIOINFORMATICS MARKET: BY SECTOR, 2021
FIGURE 24 ASIA PACIFIC BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)
FIGURE 25 ASIA PACIFIC BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)
FIGURE 26 ASIA PACIFIC BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC BIOINFORMATICS MARKET: BY APPLICATION, 2021
FIGURE 28 ASIA PACIFIC BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 29 ASIA PACIFIC BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 30 ASIA PACIFIC BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC BIOINFORMATICS MARKET: BY PURCHASE MODE, 2021
FIGURE 32 ASIA PACIFIC BIOINFORMATICS MARKET: BY PURCHASE MODE, 2022-2029 (USD MILLION)
FIGURE 33 ASIA PACIFIC BIOINFORMATICS MARKET: BY PURCHASE MODE, CAGR (2022-2029)
FIGURE 34 ASIA PACIFIC BIOINFORMATICS MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 35 ASIA PACIFIC BIOINFORMATICS MARKET: BY METHOD, 2021
FIGURE 36 ASIA PACIFIC BIOINFORMATICS MARKET: BY METHOD, 2022-2029 (USD MILLION)
FIGURE 37 ASIA PACIFIC BIOINFORMATICS MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 38 ASIA PACIFIC BIOINFORMATICS MARKET: BY METHOD, LIFELINE CURVE
FIGURE 39 ASIA PACIFIC BIOINFORMATICS MARKET: BY END USER, 2021
FIGURE 40 ASIA PACIFIC BIOINFORMATICS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 41 ASIA PACIFIC BIOINFORMATICS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 42 ASIA PACIFIC BIOINFORMATICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 43 ASIA-PACIFIC BIOINFORMATICS MARKET: SNAPSHOT (2021)
FIGURE 44 ASIA-PACIFIC BIOINFORMATICS MARKET: BY COUNTRY (2021)
FIGURE 45 ASIA-PACIFIC BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 46 ASIA-PACIFIC BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 47 ASIA-PACIFIC BIOINFORMATICS MARKET: BY TYPE (2022-2029)
FIGURE 48 ASIA PACIFIC BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.